GNH USA

Europe — EMA

Mycospor (Bifonazole)

GNH USA supplies Mycospor (Bifonazole), a imidazole antifungal for dermatophyte infections and cutaneous candidiasis. Request a quote for global supply.

Bifonazole

Request sourcing

1
Pack/s

What is Bifonazole?

Bifonazole, the active ingredient in Mycospor, is an imidazole antifungal presented as a topical formulation for skin use. It treats superficial fungal infections such as athlete's foot, ringworm and cutaneous candidiasis by targeting the fungal cell membrane. GNH USA supplies Mycospor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Bifonazole used for?

Mycospor is an imidazole antifungal indicated for superficial fungal infections of the skin. - Athlete's foot (tinea pedis): reduces fungal growth and relieves itching and scaling. - Ringworm (tinea corporis): clears skin lesions and prevents spread of infection. - Cutaneous candidiasis: eliminates Candida species on the skin and improves erythema and discomfort.

What are the side effects of Bifonazole?

Topical bifonazole may cause local reactions, most of which are mild and self‑limiting.

Common Side Effects: - Burning sensation at the application site. - Mild itching or pruritus. - Redness or erythema. - Skin irritation or dryness.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or blistering. - Severe skin reactions such as Stevens‑Johnson syndrome. - Persistent ulceration or necrosis of the treated area. - Systemic hypersensitivity reactions (rare).

What precautions apply to Bifonazole?

Before using Mycospor, consider the following safety measures. - Avoid use on broken or inflamed skin: application may increase irritation. - Do not apply to mucous membranes or eyes: product is for external skin only. - Discontinue if severe irritation or allergic reaction occurs: seek medical advice. - Monitor infection response: if lesions worsen, consult a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct light.

What does Bifonazole interact with?

Mycospor may interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use with other azole‑containing topical antifungals: may increase local irritation. - Use together with systemic azole antifungals: potential for increased systemic absorption.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may mask signs of infection progression. - Use with skin sensitizers or irritants: monitor for enhanced dermatitis. - Application under occlusive dressings: may raise drug exposure and irritation risk.

Frequently asked questions

What is Mycospor used for?+
Mycospor is a topical antifungal medication indicated for the treatment of superficial fungal infections of the skin, including athlete's foot (tinea pedis), ringworm (tinea corporis) and cutaneous candidiasis. It works by eliminating the fungi that cause these conditions, helping to relieve symptoms such as itching, redness and scaling.
How does bifonazole work?+
Bifonazole belongs to the imidazole class of antifungals. It blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Without ergosterol, the membrane becomes unstable, leading to fungal cell death and clearance of the infection.
What is the usual dose of Mycospor?+
The dosage regimen for Mycospor is determined by the prescribing healthcare professional based on the type and severity of the infection. Typically, a thin layer is applied to the affected area once or twice daily for a period prescribed by the clinician, often ranging from one to four weeks.
Is Mycospor safe during pregnancy or breastfeeding?+
Safety data for bifonazole in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.
How do I order Mycospor from GNH USA?+
To order Mycospor, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.
How does Mycospor compare with other antifungal options?+
Mycospor (bifonazole) is an imidazole antifungal, similar in spectrum to clotrimazole and miconazole. Compared with some allylamine agents such as terbinafine, bifonazole may have a slightly slower onset but is effective against a broad range of dermatophytes and Candida species. Choice of therapy often depends on clinician preference, formulation availability and patient tolerance.
How should Mycospor be stored and handled?+
Mycospor should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight. Do not freeze the product, and keep it out of reach of children.
How is Mycospor applied?+
Mycospor is applied topically to clean, dry skin. A thin film should be spread over the affected area and a small margin of surrounding healthy skin, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application, and the treated area should be allowed to dry before covering.
What are the most serious risks associated with Mycospor?+
While most reactions are mild, serious adverse events can include allergic contact dermatitis, severe skin reactions such as Stevens‑Johnson syndrome, and extensive ulceration of the treated area. If any signs of a severe reaction appear—such as swelling, blistering, fever, or widespread rash—stop use immediately and seek medical attention.
Who should not use Mycospor?+
Mycospor should not be used on broken, severely inflamed or infected skin where the barrier is compromised. Individuals with known hypersensitivity to bifonazole or any other imidazole antifungal should avoid it. It is also contraindicated for use on mucous membranes, the eyes, or in patients where systemic absorption could pose a risk without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Bifonazole
Route
Cutaneous Use
Manufacturer
Bayer Bv
Origin
EU

Related products

Amycor

Amycor

Bifonazole

Merck Santé S.A.S.
EU
Azolmen

Azolmen

Bifonazole

A. Menarini - Industrie Farmaceutiche Riunite - S.R.L.
EU
Biazol

Biazol

Bifonazole

Gedeon Richter România S.A.
EU
Bifon

Bifon

Bifonazole

Dermapharm Ag
EU